- Home
- CLOV vs LMAT Comparison
CLOV vs LMAT Comparison
Compare CLOV & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLOV
- LMAT
- Stock Information
- Founded
- CLOV 2014
- LMAT 1983
- Country
- CLOV United States
- LMAT United States
- Employees
- CLOV N/A
- LMAT N/A
- Industry
- CLOV Medical Specialities
- LMAT Medical/Dental Instruments
- Sector
- CLOV Health Care
- LMAT Health Care
- Exchange
- CLOV Nasdaq
- LMAT Nasdaq
- Market Cap
- CLOV 1.9B
- LMAT 1.9B
- IPO Year
- CLOV N/A
- LMAT 2006
- Fundamental
- Price
- CLOV $3.85
- LMAT $81.50
- Analyst Decision
- CLOV Strong Buy
- LMAT Buy
- Analyst Count
- CLOV 3
- LMAT 7
- Target Price
- CLOV $4.83
- LMAT $100.67
- AVG Volume (30 Days)
- CLOV 5.1M
- LMAT 188.6K
- Earning Date
- CLOV 05-06-2025
- LMAT 05-01-2025
- Dividend Yield
- CLOV N/A
- LMAT 0.97%
- EPS Growth
- CLOV N/A
- LMAT 30.45
- EPS
- CLOV N/A
- LMAT 1.97
- Revenue
- CLOV $1,486,073,000.00
- LMAT $226,256,000.00
- Revenue This Year
- CLOV $47.67
- LMAT $11.00
- Revenue Next Year
- CLOV $13.64
- LMAT $8.48
- P/E Ratio
- CLOV N/A
- LMAT $41.43
- Revenue Growth
- CLOV N/A
- LMAT 13.19
- 52 Week Low
- CLOV $0.79
- LMAT $71.42
- 52 Week High
- CLOV $4.87
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- CLOV 57.99
- LMAT 42.02
- Support Level
- CLOV $3.26
- LMAT $78.01
- Resistance Level
- CLOV $3.90
- LMAT $83.51
- Average True Range (ATR)
- CLOV 0.15
- LMAT 3.22
- MACD
- CLOV 0.04
- LMAT -0.83
- Stochastic Oscillator
- CLOV 71.97
- LMAT 23.07
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.